GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Research & Development

Diva Laboratories (ROCO:4153) Research & Development : NT$70.8 Mil (TTM As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Diva Laboratories's Research & Development for the three months ended in Mar. 2025 was NT$17.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was NT$70.8 Mil.

Diva Laboratories Research & Development Historical Data

The historical data trend for Diva Laboratories's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Research & Development Chart

Diva Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.58 69.52 82.62 69.16 71.90

Diva Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.97 18.77 17.66 16.50 17.92

Diva Laboratories Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$70.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diva Laboratories  (ROCO:4153) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Diva Laboratories Research & Development Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Diva Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Research & Development
Comparable Companies
ROCO:4160 ROCO:1784 TPE:6645 ROCO:6847 ROCO:6939 ROCO:6615 ROCO:7595 ROCO:6661 TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT DGX LH
Traded in Other Exchanges
N/A
Address
Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235
Website
http://www.diva.com.tw
Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines